JP2023505301A5 - - Google Patents
Info
- Publication number
- JP2023505301A5 JP2023505301A5 JP2022534233A JP2022534233A JP2023505301A5 JP 2023505301 A5 JP2023505301 A5 JP 2023505301A5 JP 2022534233 A JP2022534233 A JP 2022534233A JP 2022534233 A JP2022534233 A JP 2022534233A JP 2023505301 A5 JP2023505301 A5 JP 2023505301A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- cell
- lymphoma
- acute lymphoblastic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962944876P | 2019-12-06 | 2019-12-06 | |
| US62/944,876 | 2019-12-06 | ||
| PCT/CA2020/051668 WO2021108918A1 (en) | 2019-12-06 | 2020-12-04 | Treatment for acute myeloid leukemia or myelodysplastic syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023505301A JP2023505301A (ja) | 2023-02-08 |
| JP2023505301A5 true JP2023505301A5 (https=) | 2023-12-11 |
Family
ID=76221282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022534233A Pending JP2023505301A (ja) | 2019-12-06 | 2020-12-04 | 急性骨髄性白血病または骨髄異形成症候群に対する治療 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12533357B2 (https=) |
| EP (1) | EP4069246A4 (https=) |
| JP (1) | JP2023505301A (https=) |
| KR (1) | KR20220124177A (https=) |
| CN (1) | CN115397429A (https=) |
| AU (1) | AU2020396807A1 (https=) |
| BR (1) | BR112022011052A2 (https=) |
| CA (1) | CA3163796A1 (https=) |
| IL (1) | IL293623A (https=) |
| MX (1) | MX2022006910A (https=) |
| TW (1) | TWI880995B (https=) |
| WO (1) | WO2021108918A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7337539B2 (ja) * | 2018-06-21 | 2023-09-04 | メディヴィル・アクチエボラーグ | 白血病療法のための塩基修飾シチジンヌクレオチド |
| JP7717842B2 (ja) | 2021-05-11 | 2025-08-04 | オリック ファーマシューティカルズ，インク． | ポロ様キナーゼ４阻害剤 |
| US20250049787A1 (en) * | 2021-12-22 | 2025-02-13 | University Health Network | Treatment for acute myeloid leukemia or lymphoma |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2465971T3 (es) | 2009-04-06 | 2014-06-09 | University Health Network | Inhibidores de quinasa y método para tratar cáncer con los mismos |
| SI2556071T1 (sl) * | 2010-04-06 | 2016-12-30 | University Health Network | Kinazni inhibitorji in njihova uporaba pri zdravljenju raka |
| ES2706066T3 (es) * | 2010-07-02 | 2019-03-27 | Univ Health Network | Procedimiento dirigido a enfermedades mutantes con PTEN y composiciones para las mismas |
| WO2012048411A1 (en) * | 2010-10-13 | 2012-04-19 | University Health Network | Plk-4 inhibitors and method of treating cancer with same |
| WO2015051304A1 (en) | 2013-10-04 | 2015-04-09 | Aptose Biosciences Inc. | Compositions, biomarkers and their use in treatment of cancer |
| HUE043194T2 (hu) * | 2013-10-18 | 2019-08-28 | Univ Health Network | PLK-4 inhibitor sója és kristályformái |
| US9566280B2 (en) | 2014-01-28 | 2017-02-14 | Massachusetts Institute Of Technology | Combination therapies and methods of use thereof for treating cancer |
| JP6617208B2 (ja) | 2017-03-31 | 2019-12-11 | ノバルティス アーゲー | 血液腫瘍におけるｈｄｍ２−ｐ５３相互作用阻害剤の用量およびレジメン |
| WO2019046949A1 (en) * | 2017-09-08 | 2019-03-14 | University Health Network | POLYTHERAPIES FOR INHIBITING KINASE 4 OF THE POLO TYPE |
| EP3720560A4 (en) * | 2017-12-06 | 2022-01-05 | Ludwig Institute for Cancer Research Ltd | METHOD OF TREATMENT OF CANCER WITH PLK4 INHIBITORS |
-
2020
- 2020-12-04 BR BR112022011052A patent/BR112022011052A2/pt unknown
- 2020-12-04 US US17/782,632 patent/US12533357B2/en active Active
- 2020-12-04 AU AU2020396807A patent/AU2020396807A1/en active Pending
- 2020-12-04 KR KR1020227023046A patent/KR20220124177A/ko active Pending
- 2020-12-04 TW TW109142965A patent/TWI880995B/zh active
- 2020-12-04 CN CN202080095784.4A patent/CN115397429A/zh active Pending
- 2020-12-04 IL IL293623A patent/IL293623A/en unknown
- 2020-12-04 EP EP20895810.8A patent/EP4069246A4/en active Pending
- 2020-12-04 CA CA3163796A patent/CA3163796A1/en active Pending
- 2020-12-04 MX MX2022006910A patent/MX2022006910A/es unknown
- 2020-12-04 WO PCT/CA2020/051668 patent/WO2021108918A1/en not_active Ceased
- 2020-12-04 JP JP2022534233A patent/JP2023505301A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023505301A5 (https=) | ||
| JP2024507938A5 (https=) | ||
| JP2012521435A5 (https=) | ||
| ES2629317T3 (es) | Tratamiento de tumores cerebrales sólidos con un derivado de rapamicina | |
| JP2022009090A5 (https=) | ||
| JP2011503063A5 (https=) | ||
| JP2023041862A5 (https=) | ||
| JP2021063088A5 (https=) | ||
| JP2015212268A5 (https=) | ||
| JP2024133474A5 (https=) | ||
| JP2022124458A5 (https=) | ||
| JP2004519493A5 (https=) | ||
| JP2023541430A5 (https=) | ||
| JP2022526850A5 (https=) | ||
| RU2020114632A (ru) | Терапевтические способы, относящиеся к ингибиторам hsp90 | |
| JP2018514549A5 (https=) | ||
| JP2009539769A5 (https=) | ||
| JP2005509662A5 (https=) | ||
| JP2006514092A5 (https=) | ||
| JP2018516936A5 (https=) | ||
| JP2023009229A5 (https=) | ||
| JP2006516571A5 (https=) | ||
| JP2022551691A5 (https=) | ||
| JP2021534160A5 (https=) | ||
| JP2020514344A5 (https=) |